222 related articles for article (PubMed ID: 6410347)
41. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
42. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). 3].
Ogawa H
Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):728-45. PubMed ID: 5388928
[No Abstract] [Full Text] [Related]
43. [Comparison of histological and cytological grading of anaplasia in 200 cases of urothelial carcinoma of the bladder].
Ciarmiello G; Bassi E; Felici E; Tasso P; Bertucci B
Minerva Urol Nefrol; 1984; 36(2):97-100. PubMed ID: 6533819
[No Abstract] [Full Text] [Related]
44. A mapping of histology and cell proliferation in human bladder cancer: an immunohistochemical study.
Igawa M; Urakami S; Shirakawa H; Shiina H; Ishibe T; Usui T; Moriyama H
Hiroshima J Med Sci; 1995 Dec; 44(4):93-7. PubMed ID: 8857231
[TBL] [Abstract][Full Text] [Related]
45. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
46. [Cyclophosphamide-induced bladder cancer: three case reports].
Kijima T; Masuda H; Suzuki M; Okada Y; Yano M; Hyochi N; Fujii Y; Kawakami S; Hayashi T; Kobayashi T; Kihara K
Hinyokika Kiyo; 2003 Aug; 49(8):483-6. PubMed ID: 14518387
[TBL] [Abstract][Full Text] [Related]
47. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
48. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
Corrado F; Lalanne G; Pizza GC
Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
[No Abstract] [Full Text] [Related]
49. [The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research)].
Bocharova OA; Matveev BP; Baryshnikov AIu; Figurin KM; Serebriakova RV; Bodrova NB
Urol Nefrol (Mosk); 1995; (2):46-7. PubMed ID: 7785120
[TBL] [Abstract][Full Text] [Related]
50. [Isolated bladder carcinoma in situ].
Algaba F
Actas Urol Esp; 1986; 10(5):303-6. PubMed ID: 3825628
[No Abstract] [Full Text] [Related]
51. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
Huben RP
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
[TBL] [Abstract][Full Text] [Related]
52. [Local chemotherapy of bladder carcinoma with mitomycin (author's transl)].
Flüchter SH; Harzmann R; Hlobil H; Erdmann W; Bichler KH
Urologe A; 1982 Jan; 21(1):24-8. PubMed ID: 6805121
[TBL] [Abstract][Full Text] [Related]
53. The effect of mitomycin C on superficial bladder cancer.
Soloway MS; Murphy WM; DeFuria MD; Crooke S; Finebaum P
J Urol; 1981 May; 125(5):646-8. PubMed ID: 6785454
[TBL] [Abstract][Full Text] [Related]
54. Current topics in the pathology of bladder cancer.
Anderson CK
Proc R Soc Med; 1973 Mar; 66(3):283-6. PubMed ID: 4698000
[No Abstract] [Full Text] [Related]
55. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
56. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
[TBL] [Abstract][Full Text] [Related]
57. Leiomyoma of the urinary bladder associated with in situ transitional cell carcinoma: report of a case and review of the literature.
Frantz BB; Finkelstein LH; Arsht DB; Manfrey SJ; Hynes L
J Am Osteopath Assoc; 1983 Apr; 82(8):574-6. PubMed ID: 6853240
[No Abstract] [Full Text] [Related]
58. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu
Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407
[TBL] [Abstract][Full Text] [Related]
59. Carcinoma in situ: comments on the pathobiology of a paradox.
Weinstein RS; Miller AW; Pauli BU
Urol Clin North Am; 1980 Oct; 7(3):523-31. PubMed ID: 7456164
[TBL] [Abstract][Full Text] [Related]
60. [Experimental and clinical studies on intravesical instillation therapy for bladder cancer].
Yamanaka H; Kaburagi Y; Imai K; Miki M
Hinyokika Kiyo; 1983 Nov; 29(11):1427-32. PubMed ID: 6428193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
